Insulin glargine

What is Insulin Glargine?

Insulin glargine is a synthetic, long-acting human insulin analogue designed to provide a steady, peakless level of insulin over an extended period. It is a crucial medication for individuals living with diabetes, specifically those with type 1 diabetes and type 2 diabetes. This medication falls under the category of long-acting insulin, meaning it works slowly over many hours to help control blood glucose levels between meals and overnight.

Originally developed to mimic the body's natural basal insulin secretion, insulin glargine is administered via subcutaneous injection, typically once daily. It is available under various brand names, including Lantus (U-100 concentration), Toujeo (U-300 concentration), and Basaglar (U-100 concentration), each with slight differences in duration and onset of action, but all providing prolonged glycemic control.

How Does it Work?

The unique mechanism of action of insulin glargine lies in its molecular structure, which allows it to precipitate into micro-precipitates upon injection into the subcutaneous tissue. This precipitation occurs due to a change in pH from the acidic solution in the vial/pen to the neutral pH of the body. From these micro-precipitates, small amounts of insulin glargine are slowly released into the bloodstream over time.

This gradual release provides a relatively constant, peakless concentration of insulin for up to 24 hours (for U-100 formulations) or even longer (up to 36 hours for U-300 Toujeo). This sustained action helps maintain stable blood sugar control throughout the day and night, preventing significant fluctuations. It primarily acts on muscle and fat cells, promoting glucose uptake and inhibiting glucose production by the liver, thereby lowering blood glucose levels.

Medical Uses

Insulin glargine is approved for the treatment of both type 1 and type 2 diabetes mellitus. In individuals with type 1 diabetes, where the pancreas produces little to no insulin, insulin glargine provides the essential basal insulin required to sustain life and prevent ketoacidosis. It is typically used in conjunction with rapid-acting insulin given with meals.

For those with type 2 diabetes, insulin glargine is often prescribed when oral antidiabetic medications are no longer sufficient to achieve target blood glucose levels, or when a patient's insulin resistance requires additional support. Its role is to provide foundational insulin coverage, helping to reduce elevated fasting and pre-meal blood sugar levels. It is an integral part of a comprehensive diabetes management plan that includes diet, exercise, and sometimes other oral or injectable medications.

Dosage

The dosage of insulin glargine is highly individualized and must be determined by a healthcare professional based on the patient's specific needs, blood glucose targets, lifestyle, and response to treatment. It is administered as a subcutaneous injection once daily, typically at the same time each day, although some individuals may benefit from twice-daily dosing in consultation with their doctor.

Common initial dosing for type 2 diabetes might be 10 units once daily, adjusted based on fasting blood glucose levels. For type 1 diabetes, the total daily insulin dose is typically split between basal (insulin glargine) and bolus (mealtime) insulins. Patients are instructed to rotate injection sites within the same general area (e.g., abdomen, thigh, upper arm) to prevent lipodystrophy. It is crucial never to mix insulin glargine with other insulins or solutions, and it should never be administered intravenously.

Side Effects

Like all medications, insulin glargine can cause side effects, although not everyone experiences them. The most common and serious side effect is hypoglycemia (low blood sugar), which can range from mild to severe. Symptoms of mild hypoglycemia include sweating, shaking, rapid heartbeat, hunger, dizziness, and confusion. Severe hypoglycemia can lead to seizures, unconsciousness, and even death if not promptly treated.

Other common side effects include injection site reactions such as pain, redness, itching, or swelling at the injection site. These are usually mild and transient. Less common side effects can include lipodystrophy (changes in fat tissue at the injection site, leading to lumps or depressions), allergic reactions (rash, hives, shortness of breath, swelling of the face or throat, which require immediate medical attention), and weight gain.

Drug Interactions

Several medications can interact with insulin glargine, potentially altering its effects on blood glucose levels. It is essential to inform your doctor about all medications you are taking, including over-the-counter drugs, supplements, and herbal remedies.

Drugs that may increase the blood-sugar-lowering effect of insulin glargine and increase the risk of hypoglycemia include other diabetes medications (e.g., oral antidiabetic agents, GLP-1 receptor agonists), ACE inhibitors, salicylates, sulfonamide antibiotics, certain antidepressants (e.g., MAOIs), and beta-blockers (which can also mask symptoms of hypoglycemia). Conversely, drugs that may decrease the blood-sugar-lowering effect and potentially lead to hyperglycemia include corticosteroids, diuretics, sympathomimetics, thyroid hormones, and atypical antipsychotics. Alcohol can also have unpredictable effects on blood sugar, either increasing or decreasing the risk of hypoglycemia.

FAQ

Q: Is Insulin Glargine the same as Lantus?

A: Yes, Lantus is one of the most well-known brand names for insulin glargine (specifically the U-100 concentration). Other brand names for insulin glargine include Toujeo (U-300 concentration) and Basaglar (U-100 concentration).

Q: How quickly does Insulin Glargine start working?

A: Insulin glargine typically begins to lower blood sugar levels within 1 to 2 hours after subcutaneous injection. Its primary characteristic is its sustained, peakless action, providing a steady insulin supply over many hours rather than a rapid onset and peak.

Q: Can Insulin Glargine be mixed with other insulins?

A: No, insulin glargine should never be mixed with any other insulin or solution. Mixing can alter its pH, which can affect its solubility and long-acting profile, potentially leading to unpredictable effects on blood glucose.

Q: What should I do if I miss a dose?

A: If you miss a dose of insulin glargine, administer it as soon as you remember. However, if it's almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not double your dose to make up for a missed one. Always consult your healthcare provider for specific guidance.

Q: Does Insulin Glargine cause weight gain?

A: Yes, weight gain is a possible side effect of insulin glargine, as insulin is an anabolic hormone that promotes the storage of glucose as fat. Regular monitoring of weight and adherence to diet and exercise plans are important.

Products containing Insulin glargine are available through trusted online pharmacies. You can browse Insulin glargine-based medications at ShipperVIP or Medicenter.

Summary

Insulin glargine is a vital long-acting insulin analogue used to manage both type 1 and type 2 diabetes by providing a steady, basal insulin supply. Its unique formulation allows for once-daily administration, offering consistent blood sugar control throughout the day and night. While generally effective, users must be vigilant for potential side effects, especially hypoglycemia, and be aware of drug interactions that can impact its efficacy.

Proper dosage, administration technique, and adherence to a comprehensive diabetes management plan are crucial for optimal outcomes. Always consult with your healthcare provider for personalized advice, dosage adjustments, and to address any concerns regarding insulin glargine or your diabetes treatment.